This coming year could bring the first treatments for kids with peanut allergies, Business Insider reports.

Two companies are competing for a market of around $3 billion. Both are seeking approval from US regulators to start selling their products.

The treatments aren’t a cure, but do reduce the risk of a dangerous allergic reaction to peanuts.

Some parents say they prefer one product over the other, but it has a key drawback.